May 1, 2018 / 10:39 AM / 24 days ago

BRIEF-Edge Therapeutics Reports Quarterly Loss Per Share $0.67

May 1 (Reuters) - Edge Therapeutics Inc:

* EDGE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* QTRLY LOSS PER SHARE BASIC AND DILUTED $0.67

* SAYS BOARD CONDUCTING A COMPREHENSIVE REVIEW OF STRATEGIC ALTERNATIVES FOCUSED ON MAXIMIZING STOCKHOLDER VALUE

* SAYS INTENDS TO STREAMLINE ITS OPERATIONS IN ORDER TO PRESERVE ITS CASH RESOURCES

* SAYS HAS RETAINED PIPER JAFFRAY & CO. TO ACT AS ITS FINANCIAL ADVISOR TO ASSIST WITH THIS REVIEW PROCESS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below